4SC Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Jason Loveridge
Chief executive officer
€519.0k
Total compensation
CEO salary percentage | 77.1% |
CEO tenure | 6.7yrs |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 14.9yrs |
Recent management updates
Recent updates
Companies Like 4SC (ETR:VSCA) Could Be Quite Risky
Jan 15We Think 4SC (ETR:VSCA) Can Afford To Drive Business Growth
Aug 04We're Not Very Worried About 4SC's (ETR:VSCA) Cash Burn Rate
Feb 13We Think 4SC (ETR:VSCA) Can Afford To Drive Business Growth
Aug 27We Think 4SC (ETR:VSC) Can Afford To Drive Business Growth
Feb 22Our Take On 4SC's (ETR:VSC) CEO Salary
Dec 30CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2022 | n/a | n/a | -€14m |
Sep 30 2022 | n/a | n/a | -€19m |
Jun 30 2022 | n/a | n/a | -€23m |
Mar 31 2022 | n/a | n/a | -€17m |
Dec 31 2021 | €519k | €400k | -€10m |
Sep 30 2021 | n/a | n/a | -€8m |
Jun 30 2021 | n/a | n/a | -€7m |
Mar 31 2021 | n/a | n/a | -€13m |
Dec 31 2020 | €716k | €400k | -€19m |
Sep 30 2020 | n/a | n/a | -€19m |
Jun 30 2020 | n/a | n/a | -€19m |
Mar 31 2020 | n/a | n/a | -€16m |
Dec 31 2019 | €679k | €377k | -€14m |
Sep 30 2019 | n/a | n/a | -€15m |
Jun 30 2019 | n/a | n/a | -€17m |
Mar 31 2019 | n/a | n/a | -€17m |
Dec 31 2018 | €669k | €340k | -€18m |
Sep 30 2018 | n/a | n/a | -€15m |
Jun 30 2018 | n/a | n/a | -€12m |
Mar 31 2018 | n/a | n/a | -€11m |
Dec 31 2017 | €539k | €340k | -€11m |
Jun 30 2017 | n/a | n/a | -€10m |
Mar 31 2017 | n/a | n/a | -€11m |
Dec 31 2016 | €119k | €95k | -€11m |
Compensation vs Market: Jason's total compensation ($USD572.03K) is above average for companies of similar size in the German market ($USD418.98K).
Compensation vs Earnings: Jason's compensation has been consistent with company performance over the past year.
CEO
Jason Loveridge
6.7yrs
Tenure
€519,000
Compensation
Dr. Jason Loveridge, B.Sc, Ph D, FRSM, has been Corporate Advisor of Resonance Health Limited since June 30, 2017. Dr. Loveridge is a Founder of Invex.Dr. Loveridge has been Chairman of Management Board a...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Deputy Chairman of Supervisory Board | 17.8yrs | €37.00k | 0.0049% € 2.3k | |
Independent Chairman of Supervisory Board | 17.8yrs | €64.00k | 0.016% € 7.3k | |
Independent Member of Supervisory Board | 14.9yrs | €23.00k | 0.00059% € 274.5 | |
Independent Member of Supervisory Board | 10.8yrs | €33.00k | no data | |
Independent Member of Supervisory Board | 8.3yrs | €37.00k | 0.0073% € 3.4k | |
Member International Scientific Expert Panel | no data | no data | no data | |
Member International Scientific Expert Panel | no data | no data | no data |
14.9yrs
Average Tenure
58yo
Average Age
Experienced Board: VSCA's board of directors are seasoned and experienced ( 14.9 years average tenure).